Johnson & Johnson Posts Higher Quarterly Sales, Raises 2023 Outlook - The Wall Street Journal
- Johnson & Johnson Posts Higher Quarterly Sales, Raises 2023 Outlook The Wall Street Journal
- JNJ Stock: The Surprising Source Of Johnson & Johnson's First-Quarter Beat | Investor's Business Daily Investor's Business Daily
- Johnson & Johnson stock declines despite Q1 earnings beat Yahoo Finance
- Johnson & Johnson expects no new Covid vaccine revenue, after shots drive earnings beat CNBC
- Johnson & Johnson Q1 Beats Street View On Strong Performance Across All Segments, Lifts Guidance, Dividends Yahoo Finance
- View Full Coverage on Google News